Mesenchymal stem cells in health and disease, Nature Reviews Immunology, vol.2, issue.9, pp.726-736, 2008. ,
DOI : 10.1038/nri2395
Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants, JAMA, vol.307, issue.11, pp.1169-1177, 2012. ,
DOI : 10.1001/jama.2012.316
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study, The Lancet Neurology, vol.11, issue.2, pp.150-156, 2012. ,
DOI : 10.1016/S1474-4422(11)70305-2
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease, Gut, vol.60, issue.6, pp.788-798, 2011. ,
DOI : 10.1136/gut.2010.214841
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, The Lancet, vol.371, issue.9624, pp.1579-1586, 2008. ,
DOI : 10.1016/S0140-6736(08)60690-X
Comparison of allogeneic vs autologous bone marrowderived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial, pp.2369-2379, 2012. ,
Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells, Human Gene Therapy, vol.22, issue.1, pp.19-26, 2011. ,
DOI : 10.1089/hum.2010.197
URL : https://hal.archives-ouvertes.fr/hal-00743942
Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow, Immunology Letters, vol.89, issue.2-3, pp.267-270, 2003. ,
DOI : 10.1016/S0165-2478(03)00108-1
Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles, Journal of Cellular Physiology, vol.55, issue.33, pp.843-851, 2011. ,
DOI : 10.1002/jcp.22408
Cell specific differences between human adipose-derived and mesenchymal???stromal cells despite similar differentiation potentials, Experimental Cell Research, vol.314, issue.7, pp.1575-1584, 2008. ,
DOI : 10.1016/j.yexcr.2007.12.022
URL : https://hal.archives-ouvertes.fr/hal-00275173
Immunological characterization of multipotent mesenchymal stromal cells. The International Society for Cellular Therapy (ISCT) working proposal ,
URL : https://hal.archives-ouvertes.fr/hal-00866729
Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression, Stem Cells, vol.98, issue.8, pp.1954-1962, 2009. ,
DOI : 10.1002/stem.118
Multipotent mesenchymal stromal cells and the innate immune system, Nature Reviews Immunology, vol.107, issue.5, pp.383-396, 2012. ,
DOI : 10.1038/nri3209
T.6. Mesenchymal Stem Cells Inhibit Natural Killer Cell Proliferation, Cytotoxicity and Cytokine Production: Role of Indoleamine 2,3-Dioxygenase and Prostaglandin E2, Clinical Immunology, vol.131, pp.1327-1333, 2008. ,
DOI : 10.1016/j.clim.2009.03.133
Reciprocal Interactions Between Human Mesenchymal Stem Cells and ???? T Cells Or Invariant Natural Killer T Cells, Stem Cells, vol.9, issue.3, pp.693-702, 2009. ,
DOI : 10.1634/stemcells.2008-0687
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.177, issue.4, pp.2080-2087, 2006. ,
DOI : 10.4049/jimmunol.177.4.2080
Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes, Blood, vol.119, issue.11, pp.2556-2567, 2012. ,
DOI : 10.1182/blood-2011-08-370908
URL : https://hal.archives-ouvertes.fr/inserm-00665887
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation, Molecular Therapy, vol.20, issue.1, pp.187-195, 2012. ,
DOI : 10.1038/mt.2011.189
Mesenchymal stem cell???educated macrophages: A novel type of alternatively activated macrophages, Experimental Hematology, vol.37, issue.12, pp.1445-1453, 2009. ,
DOI : 10.1016/j.exphem.2009.09.004
Mesenchymal stromal cell ???licensing???: a multistep process, Leukemia, vol.65, issue.9, pp.1408-1414, 2011. ,
DOI : 10.1038/leu.2011.108
Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State, Stem Cells, vol.23, issue.7, pp.1753-1760, 2007. ,
DOI : 10.1634/stemcells.2007-0068
Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils, STEM CELLS, vol.52, issue.6, pp.1001-1011, 2011. ,
DOI : 10.1002/stem.651
Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase, Cancer Research, vol.69, issue.7, pp.3228-3237, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-3000
URL : https://hal.archives-ouvertes.fr/inserm-00869384
Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells, Frontiers in Immunology, vol.3, p.212, 2012. ,
DOI : 10.3389/fimmu.2012.00212
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties, Blood, vol.114, issue.13, pp.2632-2638, 2009. ,
DOI : 10.1182/blood-2009-02-207795
Regulatory T Cells, Stem Cells, vol.33, issue.1, pp.212-222, 2008. ,
DOI : 10.1634/stemcells.2007-0554
URL : https://hal.archives-ouvertes.fr/inserm-00483522
Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-??B signaling in resident macrophages, Blood, vol.118, issue.2, pp.330-338, 2011. ,
DOI : 10.1182/blood-2010-12-327353
Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6, Cell Stem Cell, vol.5, issue.1, pp.54-63, 2009. ,
DOI : 10.1016/j.stem.2009.05.003
Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury, Proceedings of the National Academy of Sciences, vol.107, issue.39, pp.16875-16880, 2010. ,
DOI : 10.1073/pnas.1012451107
Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-??-induced protein 6, Stem Cell Research & Therapy, vol.2, issue.3, p.27, 2011. ,
DOI : 10.1073/pnas.1008117107
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide, Cell Stem Cell, vol.2, issue.2, pp.141-150, 2008. ,
DOI : 10.1016/j.stem.2007.11.014
Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype, The Journal of Immunology, vol.182, issue.12, pp.7963-7973, 2009. ,
DOI : 10.4049/jimmunol.0803864
Clinical-grade mesenchymal stromal cells produced under various GMP processes differ in their immunomodulatory properties: Standardization of immune quality controls, Stem Cells Dev, 2013. ,
Secretion profile of human bone marrow stromal cells: Donor variability and response to inflammatory stimuli, Cytokine, vol.50, issue.3, pp.317-321, 2010. ,
DOI : 10.1016/j.cyto.2010.01.004
Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells, Cell Stem Cell, vol.10, issue.1, pp.9-10, 2012. ,
DOI : 10.1016/j.stem.2011.12.005
URL : https://hal.archives-ouvertes.fr/inserm-00817456
Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells, Molecular and Cellular Biology, vol.32, issue.8, pp.1433-1441, 2012. ,
DOI : 10.1128/MCB.06315-11
DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells, Aging Cell, vol.58, issue.Suppl, pp.54-63, 2010. ,
DOI : 10.1111/j.1474-9726.2009.00535.x
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression, Annual Review of Pathology: Mechanisms of Disease, vol.5, issue.1, pp.99-118, 2010. ,
DOI : 10.1146/annurev-pathol-121808-102144
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy, Biology of Blood and Marrow Transplantation, vol.18, issue.4, pp.557-564, 2012. ,
DOI : 10.1016/j.bbmt.2011.07.023
The mesenchymal stromal cells dilemma -does a negative phase III trial of random donor mesenchymal stromal cells in steroidresistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy, pp.2-8, 2013. ,
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-?? licensing, Cytotherapy, vol.14, issue.2, pp.147-152, 2012. ,
DOI : 10.3109/14653249.2011.623691
Lymphotoxin-?? Receptor Signaling through NF-??B2-RelB Pathway Reprograms Adipocyte Precursors as Lymph Node Stromal Cells, Immunity, vol.37, issue.4, pp.721-734, 2012. ,
DOI : 10.1016/j.immuni.2012.06.010
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche, Nature, vol.25, issue.7350, pp.216-219, 2011. ,
DOI : 10.1038/nature10160
Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands, Immunity, vol.34, issue.4, pp.590-601, 2011. ,
DOI : 10.1016/j.immuni.2011.02.016
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation, European Journal of Haematology, vol.34, issue.3, pp.220-227, 2012. ,
DOI : 10.1111/j.1600-0609.2012.01824.x
Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase, Leukemia, vol.176, issue.4, pp.648-654, 2011. ,
DOI : 10.1016/j.humimm.2004.02.022
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring, Leukemia, vol.26, issue.7, pp.1681-1684, 2012. ,
DOI : 10.3960/jslrt.50.79
Mesenchymal Stromal Cell Infusions as Rescue Therapy for Corticosteroid-Refractory Adult Autoimmune Enteropathy, Mayo Clinic Proceedings, vol.87, issue.9, pp.909-914, 2012. ,
DOI : 10.1016/j.mayocp.2012.04.014